![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
GLP-1 Receptor Agonists and Cardiovascular Benefit (AJMCtv) View |
![]() |
Cardiovascular Outcomes With GLP-1 Receptor Agonists in Type 2 Diabetes (AJMCtv) View |
![]() |
GLP-1 Agonists in T2D: Cardiovascular Outcomes Data (HCPLive) View |
![]() |
How do GLP-1 agonists (Ozempic, Wegovy, Mounjaro) effect heart rate and heart rate variablity (Peter Attia MD) View |
![]() |
Fundamentals of SGLT2i's and GLP-1RA's for CV Risk (American College of Cardiology) View |
![]() |
SGLT2 Inhibitors vs GLP-1 Agonists: A Cardiologist and an Endocrinologist Weigh In (Medscape) View |
![]() |
Episode 24 - SGLT2i vs GLP-1RA, Finerenone u0026 eGFR Drop, and Carbs in Dialysis (Podocyte Talk - Dr. Anass Qasem) View |
![]() |
Understanding Cardiovascular Benefit With the LEADER Trial (AJMCtv) View |
![]() |
Safe and Effective Use of SGLT2i's and GLP-1RA's in Your Cardiology Practice (American College of Cardiology) View |
![]() |
Using GLP-1 Agonists in Patients With T2D and CVD (HCPLive) View |